Randomized controlled trial assessed lifestyle changes in 52 patients at risk of cardiovascular diseases, indicating visualization's potential role in health management.
Cardiovascular diseases (CVDs) are the leading global cause of death and addressing unhealthy lifestyles is essential for reducing CVD risk. Visual explanations, such as the Petal-X dashboard, can support personalized care by improving patients' understanding of health risks and motivating lifestyle changes. This study evaluated whether the Petal-X dashboard, utilizing the SCORE2 model for 10-year CVD risk calculation, promotes lifestyle changes and subsequently reduces CVD risk. A randomized controlled trial (RCT) was conducted with 52 participants in a Slovenian Community Health Centre. After six months, changes in SCORE2 were assessed. The results showed no significant differences between the groups in reducing SCORE2 (χ2 = 0.879; p = 0.348) or other measures between groups. However, the trend suggests SCORE2 visualization may contribute moderately to CVD risk reduction, indicating potential benefits that warrant further study with larger samples and longer follow-up.
No takes yet. Share an insight, caveat, or question.
Svenšek et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: